Genetic testing company 23andMe has filed for bankruptcy after struggling with financial difficulties and strategic missteps. As the company prepares for a sale, concerns are growing over what will ...

Me might have filed for bankruptcy, but the transformation it brought to health care over nearly two decades is irreversible, ...

Over the weekend, biotechnology company 23andMe filed for Chapter 11 bankruptcy. Questions remain over what could happen to ...

Federal Trade Commission Chairman Andrew Ferguson said he's keeping an eye on 23andMe's bankruptcy proceeding and the company's planned sale because of privacy concerns related to genetic testing ...

The bankruptcy of 23andMe highlights a lack of protections for genetic privacy in the U.S.

A Strategic Move? The Chapter 11 filing indicates that 23andMe will enter a court-supervised sale or auction of its assets. Mark Jensen, a board member, has stated that this is the "best path forward ...

Genetic testing company 23andMe said it has begun bankruptcy proceedings, seeking to maximize value through a ...

The DNA of millions of people could be up for sale, as testing company 23andme filed for bankruptcy this week. Here’s how to ...

In a shocking development for investors and fans of genetic testing, 23andMe (ME) shares are plummeting, set to open around $1 this Monday morning after the company filed for Chapter 11 bankruptcy.

23andMe filed for Chapter 11 bankruptcy on Sunday. The company says no changes will be made to how it stores, manages or protects customer data up until the sale of its assets is finalized.